VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 43 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $37,772,000 | 15.45% |
| EcoR1 Capital, LLC | 4,753,907 | $28,096,000 | 0.97% |
| ARMISTICE CAPITAL, LLC | 2,564,000 | $15,153,000 | 0.26% |
| Harvest Investment Services, LLC | 42,312 | $250,000 | 0.19% |
| Aevitas Wealth Management, Inc. | 22,000 | $130,000 | 0.09% |
| CAXTON ASSOCIATES LP | 136,592 | $807,000 | 0.08% |
| XTX Topco Ltd | 25,525 | $151,000 | 0.06% |
| BVF INC/IL | 140,000 | $827,000 | 0.04% |
| FIDUCIARY TRUST CO | 248,529 | $1,469,000 | 0.03% |
| MYDA Advisors LLC | 12,000 | $71,000 | 0.02% |